Tipranks Press Release.
Detailed price information for Lunai Bioworks Inc (LNAI-Q) from The Globe and Mail including charting and trades.
--Lunai Bioworks, Inc., a biology-first AI drug discovery company, today announced an exclusive worldwide license and collaboration agreement with Tanaist, Inc. that adds human cellular phenotyping to Lunai's growing Parkinson's disease discovery and validation platform. The collaboration is designed to connect patient subtypes identified by...
Lunai Bioworks, Inc. (Nasdaq: LNAI) ("Lunai" or the "Company") today shared results from a technical case study conducted by its BioSymetrics subsidiary, supporting the development of structure-based screening tools for chemical outputs generated by large language models and other artificial intelligence systems. The study evaluates predicting acetylcholinesterase ("AChE") inhibition directly from molecular structure as a model-agnostic component of the Company's broader chemical-safety and bios
Lunai Bioworks, Inc. (Nasdaq: LNAI) ("Lunai" or the "Company") today announced the filing of its Second Amended Complaint naming six registered broker-dealers and two broker-dealer principals as defendants for the first time, in the U.S. District Court for the District of Delaware (Civil Action No. 26-549-CFC).
This is the newest page. Registered accounts read further back.